The exacerbated glucose intolerance and hyperglycemia in HFD-treated Nod1beta-cko mice was not due to insulin resistance, because HFD-treated Nod1 Nod1beta-cko mice were not more insulin resistant than the control mice (Supplementary Information, Fig. S8g). This evidence concerns the gene NOD1 and Insulin resistance.